Blog

  • Yasmin Qureshi – 2014 Parliamentary Question to the Department of Health

    Yasmin Qureshi – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Yasmin Qureshi on 2014-06-17.

    To ask the Secretary of State for Health, what steps his Department is taking to raise awareness of kidney disease among the Black, Asian and Minority Ethnic community.

    Jane Ellison

    The Department is not currently undertaking any work to raise awareness of kidney disease among black, asian and minority ethnic communities. However, local National Health Service organisations can undertake such campaigns should they wish to do so.

    The NHS Choices Website contains detailed information on both black and asian health issues which includes a page on the increased risk these ethnic groups have of developing kidney disease. The page can be viewed at the following link.

    www.nhs.uk/Livewell/Kidneyhealth/Pages/BlackandAsiankidneyhealth.aspx

    We are identifying kidney disease earlier through the NHS Health Check. This programme identifies those aged between 40 and 74 at risk of cardiovascular diseases and helps them to reduce that risk. We anticipate that up to 20,000 cases of kidney disease and diabetes (a contributing factor) could be prevented through the programme.

  • Jamie Reed – 2014 Parliamentary Question to the Department of Health

    Jamie Reed – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jamie Reed on 2014-06-17.

    To ask the Secretary of State for Health, what correspondence he has received on concerns over the potential closure of GP surgeries in the last year.

    Dr Daniel Poulter

    A search of the Department’s Ministerial correspondence database has identified 410 items of correspondence received since 1 June 2013 about concerns over the potential closure of general practitioner surgeries. The cost of a more comprehensive search would incur a disproportionate cost to the Department.

  • Roger Godsiff – 2014 Parliamentary Question to the Department of Health

    Roger Godsiff – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Roger Godsiff on 2014-06-17.

    To ask the Secretary of State for Health, what steps he has taken to ensure that patient data extracted under care.data shared with countries inside the European Economic Area cannot be shared outside that area.

    Dr Daniel Poulter

    The Data Protection Act (1998) allows personal data to be transferred to countries within the European Economic Area (EEA) on the same basis as transferring data within the United Kingdom. Personal data can only be sent to a country or territory outside the EEA if an adequate level of protection for the rights and freedoms of individuals when processing their personal data is ensured.

    Every application for information will be considered by the Health and Social Care Information Centre (HSCIC), in line with the Data Protection Act, taking account of their location if it is outside the UK.

    Recipients of data from the HSCIC must agree to certain terms and conditions of use, i.e. a data sharing contract, before any data is disclosed. Those terms and conditions include measures intended to safeguard the use of information that may identify individuals, including:

    – limiting the use of information to a specific purpose, which must also be both legitimate, compatible and shared only for the benefit of the health and social care system;

    – prohibiting onward disclosure of information to an additional organisation;

    – ensuring the security of the data once it is in the possession of another organisation that applied successfully for the data; and

    – the right of HSCIC to audit where it is suspected the terms and conditions have not been complied with.

    The HSCIC announced on 17 June 2014 that a new, strengthened audit function will monitor adherence to data sharing agreements and halt the flow of data if there are any concerns exposed. This will include scrutiny of how the data is being used and stored by those receiving it. This will also monitor that data has been deleted when an agreement comes to the end. Any failure on the part of data users to abide by their agreements will entail no further release of data to them.

  • Jim Shannon – 2014 Parliamentary Question to the Department of Health

    Jim Shannon – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2014-06-17.

    To ask the Secretary of State for Health, when he plans to publish the results of the investigation of the recent death of babies due to bacillus cereus.

    Jane Ellison

    Bacillus cereus is a spore forming bacterium found widely in the environment in dust, soil and vegetation. There is limited prevention as it is a naturally occurring bacterium. However, the Food Standards Agency has published advice on their website which details information on potential food poisoning caused by Bacillus cereus.

    The Medicines and Healthcare products Regulatory Agency (MHRA) undertake inspections of manufacturing facilities with reference to the standards of Good Manufacturing Practice to verify that companies are producing medicines that are of the correct quality and safety. The manufacture of sterile products, such as Total Parental Nutrition, is subject to special requirements in order to minimise risks of bacterial contamination.

    In the case of medicines, the MHRA and Public Health England (PHE) are currently investigating what has caused the recent incident where Total Parenteral Nutrition became contaminated with Bacillus cereus . Based on the information we currently have, we believe this is an isolated incident and the appropriate immediate action has been taken to avoid a recurrence.

    The devolved administrations have been informed of the current incident involving Bacillus cereus. The investigations into the cause of this incident are still ongoing. The Department will continue to discuss matters with the devolved administrations for minimising Bacillus cereus infection.

    The investigations being undertaken by MHRA and PHE are in their advanced stages and preliminary findings will be published as soon as possible. While the MHRA and PHE are undertaking their own investigations, it would be normal practice for the Coroner to report on the individual case he is currently considering.

  • Jim Shannon – 2014 Parliamentary Question to the Department of Health

    Jim Shannon – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2014-06-17.

    To ask the Secretary of State for Health, what discussions he has had with devolved regional assemblies to agree a strategy to prevent bacillus cereus infections.

    Jane Ellison

    Bacillus cereus is a spore forming bacterium found widely in the environment in dust, soil and vegetation. There is limited prevention as it is a naturally occurring bacterium. However, the Food Standards Agency has published advice on their website which details information on potential food poisoning caused by Bacillus cereus.

    The Medicines and Healthcare products Regulatory Agency (MHRA) undertake inspections of manufacturing facilities with reference to the standards of Good Manufacturing Practice to verify that companies are producing medicines that are of the correct quality and safety. The manufacture of sterile products, such as Total Parental Nutrition, is subject to special requirements in order to minimise risks of bacterial contamination.

    In the case of medicines, the MHRA and Public Health England (PHE) are currently investigating what has caused the recent incident where Total Parenteral Nutrition became contaminated with Bacillus cereus . Based on the information we currently have, we believe this is an isolated incident and the appropriate immediate action has been taken to avoid a recurrence.

    The devolved administrations have been informed of the current incident involving Bacillus cereus. The investigations into the cause of this incident are still ongoing. The Department will continue to discuss matters with the devolved administrations for minimising Bacillus cereus infection.

    The investigations being undertaken by MHRA and PHE are in their advanced stages and preliminary findings will be published as soon as possible. While the MHRA and PHE are undertaking their own investigations, it would be normal practice for the Coroner to report on the individual case he is currently considering.

  • Jim Shannon – 2014 Parliamentary Question to the Department of Health

    Jim Shannon – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2014-06-17.

    To ask the Secretary of State for Health, what steps the Minister is taking to prevent bacillus cereus infections in the UK.

    Jane Ellison

    Bacillus cereus is a spore forming bacterium found widely in the environment in dust, soil and vegetation. There is limited prevention as it is a naturally occurring bacterium. However, the Food Standards Agency has published advice on their website which details information on potential food poisoning caused by Bacillus cereus.

    The Medicines and Healthcare products Regulatory Agency (MHRA) undertake inspections of manufacturing facilities with reference to the standards of Good Manufacturing Practice to verify that companies are producing medicines that are of the correct quality and safety. The manufacture of sterile products, such as Total Parental Nutrition, is subject to special requirements in order to minimise risks of bacterial contamination.

    In the case of medicines, the MHRA and Public Health England (PHE) are currently investigating what has caused the recent incident where Total Parenteral Nutrition became contaminated with Bacillus cereus . Based on the information we currently have, we believe this is an isolated incident and the appropriate immediate action has been taken to avoid a recurrence.

    The devolved administrations have been informed of the current incident involving Bacillus cereus. The investigations into the cause of this incident are still ongoing. The Department will continue to discuss matters with the devolved administrations for minimising Bacillus cereus infection.

    The investigations being undertaken by MHRA and PHE are in their advanced stages and preliminary findings will be published as soon as possible. While the MHRA and PHE are undertaking their own investigations, it would be normal practice for the Coroner to report on the individual case he is currently considering.

  • Jim Shannon – 2014 Parliamentary Question to the Department of Health

    Jim Shannon – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2014-06-17.

    To ask the Secretary of State for Health, how many people were infected with bacillus cereus in each of the last five years.

    Jane Ellison

    The numbers of reported patient infection episodes of Bacillus cereus, isolated from blood samples from all age-groups between 2009 and 2013 in England, are shown in the following table.

    Year

    Number of patient infection episodes

    Organism name

    Specimen type

    Country

    2009

    50

    Bacillus Cereus

    Blood

    England

    2010

    46

    Bacillus Cereus

    Blood

    England

    2011

    39

    Bacillus Cereus

    Blood

    England

    2012

    37

    Bacillus Cereus

    Blood

    England

    2013

    56

    Bacillus Cereus

    Blood

    England

    These data were extracted from Public Health England’s centralised microbiology database (LabBase2), which collects voluntarily reported microbiology data from participating laboratories across England. Although only clinically significant isolates should be reported to LabBase2, some of the reports may be contaminants that occurred either during collection or during processing of samples as B. cereus is a ubiquitous environmental organism.

  • Julian Huppert – 2014 Parliamentary Question to the Department of Health

    Julian Huppert – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Julian Huppert on 2014-06-17.

    To ask the Secretary of State for Health, how much his Department has spent from its research and development budget over the last five years; and how much such spending is planned for (a) 2014-15 and (b) 2015-16.

    Dr Daniel Poulter

    Revenue expenditure from the Department’s research and development budget is shown in the following table:

    £ million

    2009-10

    2010-11

    2011-12

    2012-13

    2013-14

    provisional

    2014-15

    planned

    885

    960

    952

    985

    1,004

    1,077

    A budget figure for 2015-16 has not yet been set. This will happen as part of standard business planning later in the year.

  • Simon Burns – 2014 Parliamentary Question to the Department of Health

    Simon Burns – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Simon Burns on 2014-06-17.

    To ask the Secretary of State for Health, what progress has been made on the development of the HIV/STI national clinical audit; and if he will make a statement.

    Jane Ellison

    The Healthcare Quality Improvement Partnership (HQIP) commissions and manages the National Clinical Audit and Patient Outcomes Programme on behalf of NHS England. The HQIP has asked for expressions of interest from suitable providers who are able to design and complete a one year feasibility study to inform any future national clinical audit of HIV and sexually transmitted infections. The contract for the work will be awarded this summer. NHS England cannot disclose the number of expressions of interest that have been received at this stage as this is commercially sensitive information.

  • Simon Burns – 2014 Parliamentary Question to the Department of Health

    Simon Burns – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Simon Burns on 2014-06-17.

    To ask the Secretary of State for Health, how many expressions of interest from eligible providers to develop the HIV/STI national clinical audit NHS England has received to date.

    Jane Ellison

    The Healthcare Quality Improvement Partnership (HQIP) commissions and manages the National Clinical Audit and Patient Outcomes Programme on behalf of NHS England. The HQIP has asked for expressions of interest from suitable providers who are able to design and complete a one year feasibility study to inform any future national clinical audit of HIV and sexually transmitted infections. The contract for the work will be awarded this summer. NHS England cannot disclose the number of expressions of interest that have been received at this stage as this is commercially sensitive information.